Olopatadine (Patanol)

Olopatadine

Novartis South Africa (Pty) Ltd

Registration

Applicant: Novartis South Africa (Pty) Ltd
Certificate holder: Novartis SA (Pty) Ltd
Registrations: 1

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Patanol EACH 1,0 ml SOLUTION CONTAINS OLOPATADINE HYDROCHLORIDE EQUIVALENT TO OLOPATADINE 1,0 mg	1 mg/mlEye drops. Solution	33018933/15.4/0189Approved 11 November 2021	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C₂₁H₂₃NO₃337.40 g/mol

2-[(11Z)-11-[3-(Dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid

Drag to rotate. Structure from PubChem CID 5281071.

SAHPRA documents

Professional information (PI)For healthcare professionals Patient information leaflet (PIL)For patients and carers

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading Wikipedia summary

Research articles

Loading PubMed articles